Zhichao Tong

786 citations
27 papers · 621 indexed · h-index 12
Topics
Nanoplatforms for cancer theranostics (5 papers)Bladder and Urothelial Cancer Treatments (4 papers)Sarcoma Diagnosis and Treatment (4 papers)
Partner nations
ChinaCanadaGermany

In The Last Decade

Zhichao Tong

26 papers receiving 617 citations

Peers

Zhichao Tong
Comparison fields: 5 of 88
  • Plant Science 301
  • Molecular Biology 211
  • Food Science 73
  • Pulmonary and Respiratory Medicine 70
  • Oncology 62
Replace Amel Bouslimi with:
Amel Bouslimi Tunisia
Masakazu Shiraiwa Japan
Xiaohua Liu China
Zhiqiang Mei China
Danjun Guo China
Eun‐Chung Jhee South Korea
Hao Jing China
Dengke Li China
Hana Jeong South Korea
Yi Qin China
Zhichao Tong relative to Amel Bouslimi Tunisia Amel Bouslimi's profile →
Citations per field
00.5×6.6×
Amel Bouslimi · 1×
Citations per year

Countries citing papers authored by Zhichao Tong

Since Specialization
Citations

This map shows the geographic impact of Zhichao Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhichao Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhichao Tong more than expected).

Fields of papers citing papers by Zhichao Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhichao Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhichao Tong. The network helps show where Zhichao Tong may publish in the future.

Co-authorship network of co-authors of Zhichao Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Zhichao Tong. A scholar is included among the top collaborators of Zhichao Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhichao Tong. Zhichao Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 6
4 2
5 10
6 18
7 8
8 12
9 1
10 3
11 48
12 55
13 27
14 35
15 86
16 25
17 179
18 44
19 24
20
[Study of inducing bone marrow-derived mesenchymal stem cells into chondrocytes in vitro].
2

About Zhichao Tong

Zhichao Tong is a scholar working on Cancer Research, Rheumatology and Biotechnology, having authored 27 papers that have together received 621 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Biochemistry (57 citations), Plant Science (301 citations) and Food Science (73 citations). Zhichao Tong has collaborated with scholars based in China, Canada and Germany. Frequent co-authors include Yanqun Xu, Zisheng Luo, Daniel Rolland, Benjamin Mimee, Dominique Roussel, Marie Thérèse Charles, Pierre‐Yves Véronneau, Li Li, Weiguo Fang and Xing Zhang. Their work appears in journals such as Journal of Clinical Oncology, Nano Letters and ACS Nano.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026